These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 19454581)
1. Pituitary-thyroid feedback in a patient with a sporadic activating thyrotropin (TSH) receptor mutation: implication that thyroid-secreted factors other than thyroid hormones contribute to serum TSH levels. Gelwane G; de Roux N; Chevenne D; Carel JC; Léger J J Clin Endocrinol Metab; 2009 Aug; 94(8):2787-91. PubMed ID: 19454581 [TBL] [Abstract][Full Text] [Related]
2. Pituitary-thyroid regulation in euthyroid patients with Graves' disease previously treated with antithyroid drugs. Buerklin EM; Schimmel M; Utiger RD J Clin Endocrinol Metab; 1976 Aug; 43(2):419-27. PubMed ID: 59733 [TBL] [Abstract][Full Text] [Related]
3. Congenital hypothyroidism with impaired thyroid response to thyrotropin (TSH) and absent circulating thyroglobulin: evidence for a new inactivating mutation of the TSH receptor gene. Tonacchera M; Agretti P; Pinchera A; Rosellini V; Perri A; Collecchi P; Vitti P; Chiovato L J Clin Endocrinol Metab; 2000 Mar; 85(3):1001-8. PubMed ID: 10720030 [TBL] [Abstract][Full Text] [Related]
4. Thyrotropin receptor autoantibodies are associated with continued thyrotropin suppression in treated euthyroid Graves' disease patients. Brokken LJ; Wiersinga WM; Prummel MF J Clin Endocrinol Metab; 2003 Sep; 88(9):4135-8. PubMed ID: 12970276 [TBL] [Abstract][Full Text] [Related]
5. The hypothalamic-pituitary-thyroid negative feedback control axis in children with treated congenital hypothyroidism. Fisher DA; Schoen EJ; La Franchi S; Mandel SH; Nelson JC; Carlton EI; Goshi JH J Clin Endocrinol Metab; 2000 Aug; 85(8):2722-7. PubMed ID: 10946871 [TBL] [Abstract][Full Text] [Related]
6. Suppression of pituitary TSH secretion in the patient with a hyperfunctioning thyroid nodule. Ridgway EC; Weintraub BD; Cevallos JL; Rack MC; Maloof F J Clin Invest; 1973 Nov; 52(11):2783-92. PubMed ID: 4201265 [TBL] [Abstract][Full Text] [Related]
7. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission. Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661 [TBL] [Abstract][Full Text] [Related]
8. Pituitary-thyroid feedback regulation in patients with Graves' disease during antithyroid drug therapy. Yamada T; Takasu N; Sato A; Aizawa T; Koizumi Y J Clin Endocrinol Metab; 1982 Jan; 54(1):83-8. PubMed ID: 6798061 [TBL] [Abstract][Full Text] [Related]
9. Pituitary unresponsiveness to thyrotropin-releasing hormone in thyrotoxic patients during chronic anti-thyroid drug therapy and in rats previously treated with excess thyroid hormone. Harada A; Kojima A; Tsukui T; Onaya T; Yamada T; Ikejiri K; Yukimura Y J Clin Endocrinol Metab; 1975 Jun; 40(6):942-8. PubMed ID: 805794 [TBL] [Abstract][Full Text] [Related]
10. Patterns off recovery of the hypothalamic-pituitary-thyroid axis in patients taken of chronic thyroid therapy. Krugman LG; Hershman JM; Chopra IJ; Levine GA; Pekary E; Geffner DL; Chua Teco GN J Clin Endocrinol Metab; 1975 Jul; 41(1):70-80. PubMed ID: 807596 [TBL] [Abstract][Full Text] [Related]
11. Physiological states and functional relation between thyrotropin and free thyroxine in thyroid health and disease: in vivo and in silico data suggest a hierarchical model. Midgley JE; Hoermann R; Larisch R; Dietrich JW J Clin Pathol; 2013 Apr; 66(4):335-42. PubMed ID: 23423518 [TBL] [Abstract][Full Text] [Related]
12. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575 [TBL] [Abstract][Full Text] [Related]
13. Low serum free thyroxine index in ambulating elderly is due to a resetting of the threshold of thyrotropin feedback suppression. Lewis GF; Alessi CA; Imperial JG; Refetoff S J Clin Endocrinol Metab; 1991 Oct; 73(4):843-9. PubMed ID: 1653784 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus. Celani MF; Bonati ME; Stucci N Diabetes Res; 1994; 27(1):15-25. PubMed ID: 7648793 [TBL] [Abstract][Full Text] [Related]
15. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism. Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562 [TBL] [Abstract][Full Text] [Related]